Literature DB >> 16237904

[External fixation of war injuries of the proximal femur].

D Mirić1, M Bumbasirević, N Radulović, A Lesić.   

Abstract

Seventeen patients with open fractures of the upper third of the femur were treated using a pelvifemoral external fixation device. All of them had grade III open fractures resulting from high-velocity missile and explosive injuries with massive foreign body contamination. Sciatic nerve injury was present in five (29.4%); abdominal viscera and thoracic wall injuries were present in two patients (11.8%). There were no major arterial injuries. Full weight bearing was allowed after clinical and radiological bone healing (average 11.5 months). Chronic osteitis with fistula and sequestra developed in two (11.8%) patients. There were no nonunions and no refractures. Minor painless limitation of hip motion persisted in all patients. Upper-third femoral open fractures due to firearms are a unique type of open fractures. They are usually highly comminuted; therefore, stable fixation is difficult or impossible to achieve using external fixation with transfixation of the fracture site. On the other hand, the risk of infection is high following intramedullary nailing. Pelvifemoral external fixation allows adequate management of the soft tissue wounds, provides stable bone fixation and allows early patient mobilization.

Entities:  

Mesh:

Year:  2005        PMID: 16237904     DOI: 10.2298/aci0502101m

Source DB:  PubMed          Journal:  Acta Chir Iugosl        ISSN: 0354-950X


  2 in total

Review 1.  Multiscale mechanobiology of de novo bone generation, remodeling and adaptation of autograft in a common ovine femur model.

Authors:  Melissa L Knothe Tate; Scott Dolejs; Sarah H McBride; R Matthew Miller; Ulf R Knothe
Journal:  J Mech Behav Biomed Mater       Date:  2011-03-16

2.  External fixation via the anterior inferior iliac spine for proximal femoral fractures in young patients.

Authors:  Qing Yang; Nong Chen; Wenqin Fu
Journal:  Open Med (Wars)       Date:  2021-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.